- Home
- PRPO vs BHAT Comparison
PRPO vs BHAT Comparison
Compare PRPO & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- BHAT
- Stock Information
- Founded
- PRPO N/A
- BHAT 2010
- Country
- PRPO United States
- BHAT China
- Employees
- PRPO N/A
- BHAT N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- BHAT Recreational Games/Products/Toys
- Sector
- PRPO Industrials
- BHAT Consumer Discretionary
- Exchange
- PRPO Nasdaq
- BHAT Nasdaq
- Market Cap
- PRPO 22.0M
- BHAT 12.3M
- IPO Year
- PRPO N/A
- BHAT 2019
- Fundamental
- Price
- PRPO $18.50
- BHAT $1.78
- Analyst Decision
- PRPO
- BHAT
- Analyst Count
- PRPO 0
- BHAT 0
- Target Price
- PRPO N/A
- BHAT N/A
- AVG Volume (30 Days)
- PRPO 16.2K
- BHAT 1.0M
- Earning Date
- PRPO 11-05-2025
- BHAT 04-30-2025
- Dividend Yield
- PRPO N/A
- BHAT N/A
- EPS Growth
- PRPO N/A
- BHAT N/A
- EPS
- PRPO N/A
- BHAT N/A
- Revenue
- PRPO $21,242,000.00
- BHAT $18,724,190.00
- Revenue This Year
- PRPO N/A
- BHAT N/A
- Revenue Next Year
- PRPO N/A
- BHAT N/A
- P/E Ratio
- PRPO N/A
- BHAT N/A
- Revenue Growth
- PRPO 27.05
- BHAT N/A
- 52 Week Low
- PRPO $3.90
- BHAT $1.51
- 52 Week High
- PRPO $22.38
- BHAT $45.00
- Technical
- Relative Strength Index (RSI)
- PRPO 61.00
- BHAT 57.02
- Support Level
- PRPO $19.40
- BHAT $1.62
- Resistance Level
- PRPO $22.38
- BHAT $2.02
- Average True Range (ATR)
- PRPO 1.38
- BHAT 0.17
- MACD
- PRPO 0.16
- BHAT 0.02
- Stochastic Oscillator
- PRPO 52.06
- BHAT 53.33
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.